close X

Download Client Registration Documents

Investor Charter

Investor Complaints Data

Client Registration Documents in Vernacular language

Home FAQ's Sitemap Feedback Download Grievance Careers E-mail Calculator
About Us Services Online Trading Depository Equity Mutual Fund Ipo Currency Research Contact Us
Market
 
Equity Analysis
  Price
- Gainers & Losers
- Weekly Gainers & Losers
- Monthly Gainers & Losers
- Out & Under Performers
- Only Buyers & Sellers
- Advances & Declines
- New Highs & Lows
- 5 Days Up & Down
  Volume
  Analysis
News Analysis
Corporate Action
Other Market
Company Profile
Derivatives
 
 
Company Background  
Natco Pharma Ltd.
 
Industry : Pharmaceuticals & Drugs House : Natco
BSE Code   524816
ISIN Demat   INE987B01026
Book Value   467.76
NSE Code NATCOPHARM
Dividend Yield %  0.58
Market Cap   184098.08
P/E   12.27
EPS   83.75
Face Value 2  
 
Incorporation Year 19-09 1981  
Registered Office Natco House,Road No 2,Banjara Hills, Hyderabad,
Telangana-500034 .
ISINNO INE987B01026  
Phone 040-23547532  
E-mail investors@natcopharma.co.in / dasaradhi@natcopharma.co.in
URL www.natcopharma.co.in
Industry Pharmaceuticals & Drugs  
Chairman V C Nannapaneni  
Managing Director V C Nannapaneni  
Company Secretary Chekuri Venkat Ramesh  
Listing BSE,NSE  
  Privacy Policy|Disclaimer|Internal Policy & Procedures |Stock Brokers and Depository Participants | Usefull Links | Circular | Details of Client Bank A/c List | Mandatory Displays
Stock Broking
BNK Securities Pvt Ltd. (ISO 9001:2015 Certified) MEMBERS OF NSE, BSE AND MSEI SEBI Registration No: INZ000220037
SEBI Registration No : MB / INM000011641 (Category I Merchant Banker), Research Analyst. Reg no INH300003520
DEPOSITORY PARTICIPANT SEBI Registration No – IN-DP-673-2022, CDSL DP ID – 12060500.
© 2009 BNK Capitals All Rights Reserved
Designed , Developed & Content Powered Accord Fintech Pvt. Ltd.